ES287273A3 - Procedure and device for the evaluation of the protombinic complex (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure and device for the evaluation of the protombinic complex (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES287273A3
ES287273A3 ES287273A ES287273A ES287273A3 ES 287273 A3 ES287273 A3 ES 287273A3 ES 287273 A ES287273 A ES 287273A ES 287273 A ES287273 A ES 287273A ES 287273 A3 ES287273 A3 ES 287273A3
Authority
ES
Spain
Prior art keywords
plasma
abscissa
concentration
activity
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES287273A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dexploitation De Marques Et Brevets SA S E M S Ste
Original Assignee
Dexploitation De Marques Et Brevets SA S E M S Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexploitation De Marques Et Brevets SA S E M S Ste filed Critical Dexploitation De Marques Et Brevets SA S E M S Ste
Publication of ES287273A3 publication Critical patent/ES287273A3/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06G—ANALOGUE COMPUTERS
    • G06G1/00—Hand manipulated computing devices
    • G06G1/14—Hand manipulated computing devices in which a straight or curved line has to be drawn from given points on one or more input scales to one or more points on a result scale

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Computer Hardware Design (AREA)
  • Cell Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Procedure and device for the evaluation of the prothrombin complex and related factors, characterized in that the representative curve, in this case a straight line, of the thrombokinetic activity of an animal tissue thromboplastin is determined by two of its points, expressed activity by the inclination of said curve established by reference to a same control plasma, namely a human plasma proceeding from blood taken in a normal subject and collected in any usual anticoagulant medium, the abscissa being the first of the two determining points the concentration said at 100% and having the second abscissa a somewhat weaker concentration, corresponding for example to a dilution of said control plasma in the middle or in the third part, after which the Quick time of any other plasma is measured under the same conditions undiluted from a blood sample taken under the same conditions and especially by prescription in m anticoagulant of identical composition, in any subject to be recognized, the point of intersection with said representative curve of the horizontal is determined, taking for order the Quick time of said undiluted plasma which is examined and directly read the concentration in prothrombin complex of said plasma examined when lowering said intersection point perpendicular to the axis of the abscissa, previously marked by increments of percentages between the two extreme concentrations, for example 50 and 100%, of the control plasma that served to prepare the representative curve of the activity of the trombroplastina put in work. (Machine-translation by Google Translate, not legally binding)
ES287273A 1962-04-28 1963-04-22 Procedure and device for the evaluation of the protombinic complex (Machine-translation by Google Translate, not legally binding) Expired ES287273A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR896032A FR1338339A (en) 1962-04-28 1962-04-28 Method for the evaluation of the prothrombin complex and related factors and device for its materialization and rational use of the results

Publications (1)

Publication Number Publication Date
ES287273A3 true ES287273A3 (en) 1964-07-16

Family

ID=8777933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES287273A Expired ES287273A3 (en) 1962-04-28 1963-04-22 Procedure and device for the evaluation of the protombinic complex (Machine-translation by Google Translate, not legally binding)

Country Status (5)

Country Link
BE (1) BE631573A (en)
CH (1) CH433821A (en)
DE (1) DE1498986A1 (en)
ES (1) ES287273A3 (en)
FR (1) FR1338339A (en)

Also Published As

Publication number Publication date
BE631573A (en)
DE1498986A1 (en) 1969-01-30
CH433821A (en) 1967-04-15
FR1338339A (en) 1963-09-27

Similar Documents

Publication Publication Date Title
Tonomura et al. On the molecular weight of myosin. II
Loeliger et al. Questions and answers on prothrombin time standardisation in oral anticoagulant control
AMOZ et al. Immunologic Studies of Hemoglobins II. Quantitative Precipitin Test Using Anti Fetal Hemoglobin Sera
NO954897L (en) Method for determining an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements
ES287273A3 (en) Procedure and device for the evaluation of the protombinic complex (Machine-translation by Google Translate, not legally binding)
Dornan et al. Plasma haemostatic factors and diabetic retinopathy
Folk et al. Distribution of potassium and sodium between serum and certain extracellular fluids in man
Kuizenga et al. The bioassay of heparin preparations
Clausen et al. Thyroid Hormone Binding Proteins in Human Serum Characterized by Immuno-Electrophoresis and Auto-Radiographic Tracings.
Vettore et al. Biosynthetic ratio of labelled globin chains in human reticulocytes, determined by electrophoresis on cellulose acetate
Mole Diurnal and sampling variations in the determination of haemoglobin
Buckley et al. Evaluation of serum immunoglobulin concentrations in the perinatal period by use of a standardized method of measurement
Ovenstone et al. Optical density differencing: a new method for the direct measurement of bilirubin in liquor amnii
Rogenfelt et al. A suggestion on how to use measurements of cadmium in blood as a cumulative dose estimate
Stumpf et al. A note on an enzymatic method of estimating chlorine
Lewis et al. Action limits for internal quality control
JPS53142259A (en) Threshold condition testing system
Pitner et al. Relation between Serum Complement and Plasma Electrophoretic Fraction Levels in Human Tuberculosis.
Verbruggen et al. Frequency of inhibitors in haemophiliacs
DE3501496A1 (en) METHOD FOR DETERMINING THE ACTIVITY OF THE COMPLEMENT SYSTEM OF THE BLOOD
JPS5218815A (en) Novel method of immunological clinical diagnosis by means of gel-preci pitation
Collier et al. Platelet-density analysis and intraplatelet granule content in young insulin-dependent diabetics
Lott et al. Factors affecting measurement of total alkaline phosphatase activity in human serum, especially wavelength accuracy.
Allen Effects of hemoglobin variants on Hb A1c determinationsusing bio-rad columns
Næraa Remarks on the Clinical use of an Oxygen Saturation Micromethod